Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier

Purpose: The brain is protected from circulating metabolites and xenobiotics by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF) barrier. Previous studies report that P-glycoprotein (P-gp) and breast Cancer resistance protein (BCRP) are expressed apically or subapically at the blood-CSF barrier (BCSFB), implying a paradoxical function to mediate blood-to-CSF transport of xenobiotics. As evidence of P-gp and BCRP activity at the BCSFB is limited, the goal of this study is to investigate functional activity of P-gp and BCRP at the murine BCSFB using a live tissue imaging approach.

Methods: The choroid plexuses (CP) forming the BCSFB were freshly isolated from mouse brain ventricles and incubated with fluorescent probes calcein-AM and BODIPY FL-Prazosin. Using quantitative fluorescence microscopy, the functional contributions of BCRP and P-gp were examined using inhibitors and mice with targeted deletion of the Abcb1a/b or Abcg2 gene.

Results: Apical transport of calcein-AM in choroid plexus epithelial (CPE) cells is sensitive to inhibition by elacridar and Ko143 but is unaffected by P-gp deletion. In wild-type mice, elacridar increased CPE accumulation of BODIPY FL-Prazosin by 220% whereas deletion of BCRP increased BODIPY FL-Prazosin accumulation by 43%. There was no change in Mdr1a/1b mRNA expression in CP tissues from the BCRP^-/- mice.

Conclusions: This study demonstrated functional activity of BCRP at the BCSFB apical membrane and provided evidence supporting an additional contribution by P-gp. These findings contribute to the understanding of transport mechanisms that regulate CSF drug concentrations, which may benefit future predictions of CNS drug disposition, efficacy, and toxicity.

CNS pharmacokinetics; P-glycoprotein; blood-CSF barrier; breast cancer resistance protein; drug transport.